Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence and risk factor of stricture after endoscopic submucosal dissection in the duodenal bulb.

Gastrointestinal endoscopy·2026
Same author

Predictors of local recurrence and piecemeal resection in duodenal underwater endoscopic mucosal resection.

iGIE : innovation, investigation and insights·2026
Same author

Prospective validation of magnified endoscopic examination with image-enhanced endoscopy as an optical biopsy for differentiating superficial duodenal epithelial tumor and non-neoplastic lesion in duodenum.

Digestion·2026
Same author

Logical memory is associated with amyloid-β positivity in patients with early Alzheimer's disease eligible for lecanemab.

Journal of Alzheimer's disease : JAD·2026
Same author

Combined GLIM-defined malnutrition and sarcopenia and the risk of 2-year mortality in adults with heart failure: A FRAGILE-HF study post hoc analysis.

JPEN. Journal of parenteral and enteral nutrition·2026
Same author

A Real-World Pharmacovigilance Analysis of the Safety Profiles Associated with Anti-MRSA Agents Using the Japanese Adverse Drug Event Report (JADER) Database.

Infectious disease reports·2026

Related Experiment Video

Updated: Sep 18, 2025

Analysis of Fucosylated Human Milk Trisaccharides in Biotechnological Context Using Genetically Encoded Biosensors
10:17

Analysis of Fucosylated Human Milk Trisaccharides in Biotechnological Context Using Genetically Encoded Biosensors

Published on: April 13, 2019

6.5K

Development of Efficiently Quantitative Analysis Targeting α-Galactosylceramide in FreeStyle 293-F Cells.

Kentaro Iwata1, Koji Nishimura2, Kanae Otsutomo3

  • 1Analytical Research Labs, Astellas Pharma Inc., 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, Japan.

Chemical & Pharmaceutical Bulletin
|June 22, 2025
PubMed
Summary

Quantifying alpha-Galactosylceramide (α-GalCer) in artificial adjuvant vector cells (aAVCs) is crucial for cancer therapy. This study developed and validated a precise LC-MS/MS method for accurate α-GalCer content determination.

Keywords:
analytical developmentartificial adjuvant vector cellinternal standard methodtandem MSvalidationα-galactosylceramide

More Related Videos

Isolation and Characterization Of Chimeric Human Fc-expressing Proteins Using Protein A Membrane Adsorbers And A Streamlined Workflow
10:33

Isolation and Characterization Of Chimeric Human Fc-expressing Proteins Using Protein A Membrane Adsorbers And A Streamlined Workflow

Published on: January 8, 2014

7.2K
SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

24.2K

Related Experiment Videos

Last Updated: Sep 18, 2025

Analysis of Fucosylated Human Milk Trisaccharides in Biotechnological Context Using Genetically Encoded Biosensors
10:17

Analysis of Fucosylated Human Milk Trisaccharides in Biotechnological Context Using Genetically Encoded Biosensors

Published on: April 13, 2019

6.5K
Isolation and Characterization Of Chimeric Human Fc-expressing Proteins Using Protein A Membrane Adsorbers And A Streamlined Workflow
10:33

Isolation and Characterization Of Chimeric Human Fc-expressing Proteins Using Protein A Membrane Adsorbers And A Streamlined Workflow

Published on: January 8, 2014

7.2K
SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

24.2K

Area of Science:

  • Immunology
  • Analytical Chemistry
  • Cancer Therapy

Background:

  • Alpha-Galactosylceramide (α-GalCer) is a lipid antigen that activates natural killer T cells.
  • Artificial adjuvant vector cells (aAVCs) are being investigated for cancer therapy, utilizing α-GalCer.
  • Accurate quantification of α-GalCer within aAVCs is necessary to ensure therapeutic efficacy.

Purpose of the Study:

  • To establish and validate a novel analytical procedure for quantifying α-GalCer content in cells.
  • To apply the validated method for determining α-GalCer levels in α-GalCer-loaded model cells.

Main Methods:

  • Development of a liquid chromatography (LC) and tandem mass spectrometry (MS) based analytical procedure.
  • Incorporation of a lipid extraction method and an internal standard method for enhanced accuracy.
  • Analytical validation of the developed quantification method.

Main Results:

  • A robust and validated LC-MS/MS method was successfully established for α-GalCer quantification.
  • The method demonstrated accuracy and precision suitable for quality control of aAVCs.
  • The procedure was effectively applied to determine α-GalCer content in model aAVCs.

Conclusions:

  • The developed LC-MS/MS method provides a reliable means to quantify α-GalCer in cellular contexts.
  • This quantification is essential for the development and clinical application of α-GalCer-based cancer immunotherapies.
  • The validated method supports the advancement of artificial adjuvant vector cell technology.